GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:17117936

From GONUTS
Jump to: navigation, search
Citation

Atkins, S, Smith, KG, Loescher, AR, Boissonade, FM, Ferguson, MW and Robinson, PP (2006) The effect of antibodies to TGF-beta1 and TGF-beta2 at a site of sciatic nerve repair. J. Peripher. Nerv. Syst. 11:286-93

Abstract

Scar formation at a site of nerve injury can cause a mechanical barrier to axonal regeneration and lead to the development of multiple axonal sprouts to form a neuroma. We have investigated the hypothesis that the application of a scar-preventing agent to a nerve repair site would enhance regeneration of the nerve and reduce neuroma formation. The left sciatic nerve was exposed under general anaesthesia in 18 adult Sprague-Dawley rats. In 12 animals, the nerve was sectioned and immediately re-approximated using four epineurial sutures, and in 6 of these animals neutralising antibodies to transforming growth factor (TGF)-beta1 and TGF-beta2 were injected into and around the repair site. The six other animals acted as controls. After 7 weeks, the outcome was assessed by recording compound action potential (CAP) ratios, measuring collagen levels using picrosirius red staining, and counting the number of myelinated axons proximal and distal to the repair. After repair alone, the mean percentage of area of staining (PAS) for collagen within the nerve had significantly increased. However, after repair with the administration of antibodies, the PAS was not significantly different from that in the sham controls. After administration of antibodies, the CAP ratios were significantly smaller than in controls but not after repair alone. In both nerve injury groups, the myelinated fibre counts were significantly increased distal to the injury site, but there was no difference between these two groups. We conclude that administration of antibodies to TGF-beta1 and TGF-beta2 reduced scar formation at the repair site but did not enhance regeneration of the nerve or reduce the development of multiple axonal sprouts.

Links

PubMed Online version:10.1111/j.1529-8027.2006.00100.x

Keywords

Action Potentials/drug effects; Animals; Antibodies/therapeutic use; Axotomy; Cicatrix/prevention & control; Male; Nerve Regeneration/drug effects; Neuroma/prevention & control; Rats; Rats, Sprague-Dawley; Sciatic Nerve/drug effects; Sciatic Nerve/immunology; Sciatic Nerve/injuries; Transforming Growth Factor beta1/antagonists & inhibitors; Transforming Growth Factor beta1/immunology; Transforming Growth Factor beta2/antagonists & inhibitors; Transforming Growth Factor beta2/immunology

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:TGFB2

involved_in

GO:0042060: wound healing

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete

RAT:TGFB1

involved_in

GO:0042060: wound healing

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete


See also

References

See Help:References for how to manage references in GONUTS.